TLDR Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.
The review discusses the potential of dissolving microneedles for transdermal delivery of therapeutic compounds. These microneedles have superior drug loading capabilities and can be made entirely from the therapeutic agent. They have applications in various areas including cosmetics, vaccine delivery, diagnosis, cancer, pain and inflammation, diabetes, hair and scalp disorders, and inflammatory skin diseases. In hair and scalp disorders, microneedles containing valproic acid and finasteride have shown promising results in promoting hair growth in mouse models. Despite their potential, challenges such as rapid skin healing, complex manufacturing processes, potential infection risks, limited dosing capacity, and regulatory and commercial barriers need to be addressed. The market for microneedles is expected to grow at a compound annual growth rate of 7.1% through to 2027.
33 citations,
November 2019 in “Journal of Controlled Release” Microneedles with enhancer effectively promote hair growth and increase hair density.
68 citations,
March 2018 in “Biomaterials” Tiny needles with valproic acid can effectively regrow hair.
131 citations,
May 2015 in “Experimental Dermatology” Microneedles help improve skin appearance and deliver skin treatments effectively, but safety concerns need more research and regulation.
21 citations,
August 2011 in “Clinics in Dermatology” Looking at skin can help find and treat serious diseases early.
67 citations,
January 2022 in “Theranostics” Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.
November 2022 in “Clinical, Cosmetic and Investigational Dermatology” The combined treatment for hair loss is effective, easy to use, and has mild side effects.
68 citations,
March 2018 in “Biomaterials” Tiny needles with valproic acid can effectively regrow hair.
14 citations,
May 2022 in “Asian Journal of Pharmaceutical Sciences” New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.
April 2024 in “Bioactive materials” New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.
